JULIA CHERRONE: Open Payments
NPI 1891494175 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 52 payments from 9 companies in 2025. Trend: 2023 $641 · 2024 $401 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $161 |
| Supernus Pharmaceuticals, Inc. | 12 | $145 |
| Corium, LLC | 11 | $131 |
| Janssen Pharmaceuticals, Inc | 5 | $119 |
| Alkermes, Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: VRAYLAR, Qelbree, Azstarys, SPRAVATO, ARISTADA, REXULTI, CAPLYTA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
